JOURNEY™ II CR Total Knee System

NCT02440672 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2025-12-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of the JOURNEY™ II CR Total Knee System in subjects with degenerative joint disease (DJD) requiring primary total knee replacement.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

JOURNEY™ II CR Total Knee System (J II CR TKS)

TKA with Journey II CR Total Knee System

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Lucy O'Mara · Smith & Nephew, Inc.

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2028-06-30
Completion
2028-06-30
FDA Device
Yes

Countries

  • United States
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02440672 on ClinicalTrials.gov